Kane Biotech amends credit facility

Jun. 15, 2022 8:32 AM ETKane Biotech Inc. (KNBIF), KNE:CABy: Deepa Sarvaiya, SA News Editor
  • Kane Biotech (OTCQB:KNBIF) amends its credit agreement with Pivot Financial maturing August 31, 2022 
  • The company extends the maturity January 31, 2023 and increases the credit facility to $4M with ~$1.8M of new capital having been provided.
  • The increased credit facility will continue to be used by the company for funding research and development relating to eligible government reimbursable expenditures and general working capital purposes.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.